Press Archive
| 2013 Press ArchiveThe ICR began a a new push to bring personalised treatments to patients, with its Tumour Profiling Unit. |
 | 2012 Press ArchiveICR-developed drug abiraterone was recommended for prostate cancer patients on the NHS, and the ICR opened the Centre for Molecular Pathology. |
 | 2011 Press ArchiveEurope's leading cancer research centre, The Institute of Cancer Research (ICR), named eminent scientist Professor Alan Ashworth as its new Chief Executive. |
| 2010 Press ArchivePhase III trial results showed that the drug abiraterone, developed at the ICR, can significantly extend overall survival for men with advanced prostate cancer. |
| 2009 Press Archive2009 marked the centenary year for the ICR, which began life as a small research laboratory in the Royal Marsden Hospital. |
| 2008 Press ArchiveThe ICR announced that the drug abiraterone could treat up to 80% of patients with aggressive and previously drug resistant prostate cancer. |
| 2007 Press ArchiveICR scientists identified two common genetic variants that could triple a person’s risk of getting bowel cancer. |
| 2006 Press ArchiveThe complex chain of molecular triggers involved in the development of malignant melanoma, the deadliest form of skin cancer, was published by the ICR. |
| 2005 Press ArchiveRachel Stevens took men's health into her own hands with an Everyman advertisement about warning signs of testicular cancer. |
| 2004 Press ArchiveA gene crucial to the advancement and spread of bladder cancer was identified, providing a new target for drug development research. |
| 2003 Press ArchiveHRH The Princess Royal, Chancellor of The University of London, officially opened the ICR’s Brookes Lawley Building at the beginning of the year. |
| 2002 Press ArchiveICR scientists linked smoking to at least 14 different types of cancer, as well as at least eight other serious medical conditions. |
| 2001 Press ArchiveScientists developed a pioneering new method for diagnosing breast cancer, helping doctors distinguish more accurately between benign and malignant tumours. |
| 2000 Press ArchiveThe ICR and The Royal Marsden developed a high-precision radiosurgery technique, allowing doctors to control a third of all brain tumours. |
| 1999 Press ArchiveScientists at the ICR developed a cancer chip which has revolutionised the way cancer genes are discovered. |
| 1998 Press ArchiveScientists began moving into the new extension of the Chester Beatty Laboratories in May, two years after construction started. |
